Recombinomics | Elegant Evolution






Home Founder What's New In The News Consulting





























H1N1 Consulting

Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents



Audio:May20 Jun17 Jul15 Aug19 RSS Feed twitter News Now                         
Live feed of underlying pandemic map data here
Commentary


Kansas H1N1 Is Tamiflu and Relenza Sensitive
Recombinomics Commentary 16:26
August 26, 2010

In vivo antiviral resistance

Adamantanes: Unknown
Oseltamivir: Sensitive
Zanamivir: Sensitive
Peramivir: Unknown
Other: Unknown
 
The GISAID antiviral characterization sheet for A/Kansas/05/2010 has been corrected as indicated above. 

The initial sheet (posted yesterday) indicated (see list here) the isolate was resistant to Oseltamivir (Tamiflu) and Zanamivir (Relenza). 

This morning the CDC contacted Recombinomics to indicate the entry was in error and likely linked to the recent GISAID upgrade of the site (which now allows BLAST analysis of the database). 

The other NA sequence released with the Kansas sequence, A/Connecticut/23/2009, has not been tested for antiviral resisitance.

Media Links

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings
















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2010 Recombinomics.  All rights reserved.